NRD
NUS icon

Nebula Research & Development’s Nu Skin NUS Stock Holding History

Nebula Research & Development’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,608
Closed -$460K – 586
2025
Q2 		$460K Sell
57,608
-9,133
-14% -$64.1K 0.04% 657
2025
Q1 		$485K Sell
66,741
-15,384
-19% -$112K 0.04% 619
2024
Q4 		$566K Sell
82,125
-32,837
-29% -$226K 0.07% 507
2024
Q3 		$847K Buy
+114,962
New +$1.07M 0.1% 359
2023
Q4 		– Sell
-17,785
Closed -$377K – 814
2023
Q3 		$377K Buy
+17,785
New +$462K 0.2% 202

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nebula Research & Development's NUS Position: Q3 2025 in Review

Nebula Research & Development sold out of Nu Skin (NUS) in Q3 2025, closing a stake of 57,608 shares — an estimated $460K sold.

Nebula Research & Development first reported a position in NUS in Q3 2023 and held it in 5 quarters. The position peaked at $847K in Q3 2024. 194 funds tracked by Wall St. Rank hold NUS as of Q3 2025.

  • Nebula Research & Development reported no remaining Nu Skin position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 57,608 Nu Skin shares in Q3 2025, an estimated $460K.
  • Nebula Research & Development first reported a position in Nu Skin in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's Nu Skin position peaked at $847K in Q3 2024.
  • 194 funds tracked by Wall St. Rank held Nu Skin as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.